Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES from Nivelles, company number BE0407221836, closed financial year 2025 with a result of € -566 after tax. For that financial year SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES recorded a gross margin of € -67 and equity of € 158,258. Compared with financial year 2024, the result moved from € -551 to € -566. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 158,258
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -566
▼ 3 % more loss than in 2024
Profit after tax over the fiscal year.
Loss, nothing to pay out
Reserves fell to € 96,258.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -493 | € -64 | € -64 | € -67 | ▼ € 3 |
| Profit after taxes | € -940 | € -548 | € -551 | € -566 | ▼ € 15 |
| Equity | € 159,923 | € 159,375 | € 158,824 | € 158,258 | |
| Total debts | € 21,875 | € 22,423 | € 22,974 | € 23,540 | ▲ 2% |
| Retained profit | € 97,923 | € 97,375 | € 96,824 | € 96,258 | ▼ 1% |
| Balance sheet total | € 181,798 | € 181,798 | € 181,798 | € 181,798 |
Key figures of SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES?
What happened at SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 566. filed late Source: NBB ↗
- New establishment in Nivelles. KBO
- Start of the company according to the CBE. KBO
In short
From € 940 loss in 2022 to € 566 loss in 2025.
A new publication or filing at SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES? We notify you, reason included.
Follow SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of C.D. PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUESBehind SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES are CD PHARMA SA and PHILIPPE DENIS. The shares are held by C.D. PHARMA (99.5%).
Directors
According to the 2025 annual accounts
Director
Shareholders
99.5%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Allée de la Tour-Renard 15
1400 Nivelles
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0407.221.836
- VAT number
- BE 0407.221.836
- Registered office
- Allée de la Tour-Renard 15, 1400 Nivelles
- Names & denominations
- SOCIETE ANONYME D'EXPLOITATION D'OFFICINES PHARMACEUTIQUES · EXOPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 3 July 1970
- Peppol
- Not registered